Description
Product Overview:
Sofokem L is a potent antiviral medication indicated for the treatment of chronic hepatitis C virus (HCV) infection. Each tablet of Sofokem L combines two active pharmaceutical ingredients, Sofosbuvir and Ledipasvir, in precise proportions to provide comprehensive therapy against HCV. Manufactured by Cytomed, a division of Alkem Laboratories Ltd., Sofokem L stands as a testament to quality and innovation in pharmaceuticals.
Key Features:
- Dual Action Formula: Sofokem L contains Sofosbuvir and Ledipasvir, two direct-acting antiviral agents that target different steps of the HCV replication cycle, resulting in potent and sustained virological response rates.
- High Strength Formulation: Each tablet of Sofokem L contains Sofosbuvir 400 mg and Ledipasvir 90 mg, ensuring adequate dosage for effective treatment outcomes.
- Convenient Dosage Form: Packaged in a blister pack containing 28 tablets, Sofokem L offers a convenient and comprehensive treatment regimen for patients.
- Manufactured by Cytomed (Alkem Laboratories Ltd.): Sofokem L is manufactured by Cytomed, a division of Alkem Laboratories Ltd., known for its commitment to excellence and adherence to global quality standards.
Indications:
Sofokem L is indicated for the treatment of chronic hepatitis C virus (HCV) infection in adults.
Usage Instructions:
Sofokem L should be taken orally once daily with or without food, as directed by a healthcare professional. The duration of treatment and combination with other medications may vary depending on the HCV genotype, prior treatment history, and presence of liver cirrhosis. It is essential to follow the prescribing physician’s instructions carefully.
Safety Information:
- Prior to initiating treatment with Sofokem L, patients should undergo thorough evaluation, including assessment of liver function, HCV genotype, and baseline viral load.
- Adverse reactions such as fatigue, headache, nausea, and insomnia may occur during treatment with Sofokem L. Patients should report any persistent or bothersome symptoms to their healthcare provider.
- Sofokem L may interact with certain medications, including antacids, rifampin, and certain antiretroviral agents. Patients should inform their healthcare provider about all medications being taken.
- Use of Sofokem L during pregnancy or breastfeeding should be carefully considered, weighing the potential risks and benefits to the mother and fetus.
Storage:
Sofokem L should be stored as per the manufacturer’s instructions, typically at controlled room temperature away from moisture and heat. Unused portions should be kept in the original packaging and out of reach of children.
Reviews
There are no reviews yet.